for the Period Ended 31 August 2025
| Directors report | |
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 August 2025
Principal activities of the company
Additional information
The corporation taxes due from the trading profits of the year ending 31 August 2024 are being offset in total by the losses of this current financial year ending 31 August 2025. There are herewith no taxes due. This company will be dissolved and struck-off immediately following this tax year ending 31 August 2025 with Form DS01 to be filed with the full accounts. The claim is herewith made to set off trading losses from the current tax year ending 31 August 2025 against its total profits of the preceding accounting period of the year ending 31 August 2024 and, as allowed under CTM04510 although not required to nullify the corporation taxes due by HMRC, all three preceding accounting years.
Directors
The director shown below has held office during the whole of the period from
1 September 2024
to
31 August 2025
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
| 2025 | 2024 | |
|---|---|---|
|
|
£ |
£ |
| Turnover: |
|
|
| Cost of sales: |
(
|
|
| Gross profit(or loss): |
( |
|
| Distribution costs: |
|
|
| Administrative expenses: |
(
|
(
|
| Other operating income: |
|
|
| Operating profit(or loss): |
( |
|
| Interest receivable and similar income: |
|
|
| Interest payable and similar charges: |
|
|
| Profit(or loss) before tax: |
( |
|
| Tax: |
|
|
| Profit(or loss) for the financial year: |
( |
|
As at
| Notes | 2025 | 2024 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Called up share capital not paid: |
|
|
|
| Fixed assets | |||
| Intangible assets: |
|
|
|
| Tangible assets: | 3 |
|
|
| Investments: |
|
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Stocks: |
|
|
|
| Debtors: |
|
|
|
| Cash at bank and in hand: |
|
|
|
| Investments: |
|
|
|
| Total current assets: |
|
|
|
| Prepayments and accrued income: |
|
|
|
| Creditors: amounts falling due within one year: |
|
|
|
| Net current assets (liabilities): |
|
|
|
| Total assets less current liabilities: |
|
|
|
| Creditors: amounts falling due after more than one year: |
|
|
|
| Provision for liabilities: |
|
|
|
| Accruals and deferred income: |
|
|
|
| Total net assets (liabilities): |
|
|
|
| Capital and reserves | |||
| Called up share capital: |
|
|
|
| Share premium account: |
|
|
|
| Other reserves: |
|
|
|
| Profit and loss account: |
|
|
|
| Total Shareholders' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 August 2025
Basis of measurement and preparation
for the Period Ended 31 August 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 31 August 2025
| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
|---|---|---|---|---|---|---|
| Cost | £ | £ | £ | £ | £ | £ |
| At 1 September 2024 |
|
|
||||
| Additions | ||||||
| Disposals | ||||||
| Revaluations | ||||||
| Transfers | ||||||
| At 31 August 2025 |
|
|
||||
| Depreciation | ||||||
| At 1 September 2024 |
|
|
||||
| Charge for year |
|
|
||||
| On disposals | ||||||
| Other adjustments | ||||||
| At 31 August 2025 |
|
|
||||
| Net book value | ||||||
| At 31 August 2025 |
|
|
||||
| At 31 August 2024 |
|
|
The principal activities of the company during this year continued to be that of specialist medical practices in the field of frequency medicine and electromagnetic therapies. The company's activities have benefited the community by providing therapeutic relief in various areas of adult human holistic healthcare.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
1 September 2025
And signed on behalf of the board by:
Name: Kasey Phifer
Status: Director